
BridgeBio Pharma, Inc. Announces Proposed Offering of $350 Million Convertible Senior Notes
03.04.2020
page
of 7
news
Catch up on news from BridgeBio and its companies and follow developments about the promising treatments in our pipeline. Follow us on LinkedIn to keep up with all the latest news.
Links to an external site